New palladium(II) and platinum(II) 5,5-diethylbarbiturate complexes with 2-phenylpyridine, 2,2’-bipyridine and 2,2’-dipyridylamine : synthesis, structures, DNA binding, molecular docking, cellular uptake, antioxidant activity and cytotoxicity

Peer reviewedPostprin

Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents

Acknowledgements The support provided by our universities (KTU, EOGU and UA) in accessing scientific databases (WOS, Scopus, SciFinder and CCDC) was greatly appreciated.Peer reviewe

Synthesis, characterization and crystal structures of platinum(II) saccharinate complexes with 1,5-cyclooctadiene

Two new platinum(II) complexes, namely [PtCl(sac)(COD)] (1) and [Pt(sac)(2) (COD)] (2) (sac = saccharinate and COD = 1,5-cyclooctadiene), were synthesized and characterized by elemental analysis, IR, NMR, ESI-MS spectroscopic and thermal analysis (TG/DTA) methods. The platinum(II) complexes were prepared from the reaction of [PtCl2 (COD)] with Na(sac)center dot 2H(2)O. The addition of the sac ligand resulted in the replacement of 1 and 2 chlorido ligands in [PtCl2 (COD)] to yield 1 and 2, respectively. The structures of the complexes were determined by single crystal X-ray diffraction and showed a distorted square planar coordination geometry around platinum(II). COD acted as a p-donor ligand, while sac was N-coordinated in both complexes. The TG/DTA data indicated that both complexes were thermally stable up to 220 degrees C in air and their thermal decompositions yielded Pt as a final product. Complexes 1 and 2 were also designed as possible precursors to synthesize new mixed-ligand platinum(II) sac complexes in a one-pot reaction

Correction: Zn(<scp>ii</scp>), Cd(<scp>ii</scp>) and Hg(<scp>ii</scp>) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines <i>via</i> ROS-induced apoptosis

Correction for ‘Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis’ by Ceyda Icsel et al., Dalton Trans., 2020, 49, 7842–7851, DOI: 10.1039/D0DT01535K.</p